How the immune system responds to sepsis
Treatments studied
Part of Infections clinical trials.
This study looks at how the immune system reacts to sepsis (a severe infection that causes organs to fail) and whether there are lasting effects on health. It may help researchers understand why some people recover well and others don’t.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a confirmed or suspected infection with organ failure (sepsis).
- You are not taking high doses of steroids (more than about 30 mg of prednisone daily for over 15 days).
- You are not currently using biologic medications (like medicines for autoimmune diseases).
- You do not have a weakened immune system due to cancer treatment, low CD4 counts, a primary immune disorder, or an organ or bone marrow transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the immune system changes during sepsis, a life-threatening infection that can cause organ failure. By studying blood samples over time, researchers hope to find better ways to treat or prevent complications.
This study looks at how the immune system works in people who are critically ill with sepsis. By understanding these changes, doctors hope to find better ways to treat this serious condition.
This study looks at how severe infections (like sepsis) affect the body's immune system over time. It may help researchers find better ways to help patients recover.
This study looks at how special cells from bone marrow (called stem cells) might help fix immune problems caused by sepsis. The goal is to see if these cells can improve how your immune system works during a severe infection.
This study looks at how the immune system changes in people with sepsis (a severe response to infection that can cause organ failure). It aims to understand immune dysfunction to help improve treatments.
This study looks at a type of immune cell called 'memory CD8+ T cells' in patients with sepsis, a life-threatening response to infection. The goal is to see if these cells are linked to how severe the sepsis is and the risk of dying. This may help doctors better predict outcomes for people with sepsis.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.